Reference
Maller B, et al. Ipilimumab/Nivolumab-related Opsoclonus-Myoclonus-Ataxia Syndrome Variant in a Patient with Malignant Pleural Mesothelioma. Journal of Immunotherapy 41: 411-412, No. 9, Nov 2018. Available from: URL: http://doi.org/10.1097/CJI.0000000000000228 - USA
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1730, 40 (2018). https://doi.org/10.1007/s40278-018-54940-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-54940-4